KRISTEN HARRINGTON-SMITH

Kristen Harrington-Smith has served as Senior Vice President & Chief Commercial Officer of ADC Therapeutics, a publicly-traded clinical-stage biopharmaceutical company, since November 2022. Prior to joining ADC Therapeutics, Ms. Harrington-Smith served as Chief Commerical Officer at ImmunoGen where she helped the organization prepare for their first commercial launch.Prior to joining ImmunoGen, Ms. Harrington-Smith held roles of increasing responsibility at Novartis Pharmaceuticals starting in July 2000, most recently as U.S. Commercial Head of Hematology from 2020 to 2021 and as Vice President and Head of U.S. CAR-T from 2016 to 2020. She holds a B.A. in Psychology, with honors, from Williams College and an MBA from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.